Movano Inc. announced the development of a beta testing program with Stanford Health Applied Sports Science Department. The beta test, which is expected to commence in the fourth quarter of 2022, will utilize the Movano Ring, Movano's first commercial product designed to track and analyze medical grade data and deliver insights to consumers across a wide spectrum of healthcare needs, and prepare the Company for its commercial launch in the first half of 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.413 USD | -1.71% | -2.59% | -47.15% |
05-15 | Transcript : Movano Inc., Q1 2024 Earnings Call, May 15, 2024 | |
05-15 | Earnings Flash (MOVE) MOVANO Reports Q1 Revenue $852,000 | MT |
1st Jan change | Capi. | |
---|---|---|
-47.15% | 44.32M | |
+10.03% | 223B | |
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+2.05% | 65.01B | |
+15.38% | 53.02B | |
+3.96% | 50.45B | |
+8.37% | 44.15B | |
+3.27% | 36.45B |
- Stock Market
- Equities
- MOVE Stock
- News Movano Inc.
- Movano Inc. Announces Beta Program with Stanford University to Advance the Development of Comprehensive Health Data Monitoring for its Wearable Ring Solution